Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · IEX Real-Time Price · USD
11.03
0.26 (2.41%)
May 27, 2022 4:00 PM EDT - Market closed
Company Description
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform.
It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada.
It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations.
The company was founded in 2013 and is based in Orange, California.
Alignment Healthcare, Inc.
Country | United States |
Founded | 2013 |
IPO Date | Mar 26, 2021 |
Industry | Health Care Providers & Services |
Sector | Health Care |
Employees | 847 |
Contact Details
Address: 1100 West Town and Country Road Orange, CA 92868 United States | |
Phone | 844 310 2247 |
Website | alignmenthealthcare.com |
Stock Details
Ticker Symbol | ALHC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | US Dollars |
IPO Price | $18.00 |
CIK Code | 1832466 |
Key Executives
Name | Position |
---|---|
John E. Kao | President, Chief Executive Officer and Director |
Robert Thomas Freeman | Chief Financial Officer |
Dr. Dinesh M. Kumar M.D. | Chief Medical and Operating Officer |
Dawn Christine Maroney | President of Markets and Chief Executive Officer of Health Plan |
Charlotte LeBlanc | Chief Accounting Officer and Senior Vice President |
Hakan Kardes | Senior Vice President and Chief Technology Officer |
Rob Scavo | Chief Information Officer |
Richard A. Cross | Senior Vice President and General Counsel |
Amanda Root | Vice President of Corporate Communications |
Supriya Sood | Chief People Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 16, 2022 | 4 | Statement of changes in beneficial ownership of securities |
May 5, 2022 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
May 5, 2022 | 8-K | Current report |
Apr 28, 2022 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 28, 2022 | DEF 14A | Other definitive proxy statements |
Apr 7, 2022 | 144 | Report of proposed sale of securities |
Apr 4, 2022 | 144 | Report of proposed sale of securities |
Apr 4, 2022 | 144 | Report of proposed sale of securities |
Apr 4, 2022 | 144 | Report of proposed sale of securities |
Apr 4, 2022 | 144 | Report of proposed sale of securities |
View All SEC Filings |